Common drug plus hormone provide one-two punch against deadly Strongyloidiasis hyperinfection being …

Combining two agents to block a parasitic worm’s life cycle boosted survival from a potentially deadly tropical disease to 85% in animal models, far better than either treatment alone, according to a proof-of-concept study led by UT Southwestern Medical Center pharmacologists.

Click here to view the original article.